龍芯中科(688047.SH):未來公司計劃推出自主編程框架,發展自主應用
格隆匯9月19日丨龍芯中科(688047.SH)在互動平台表示,信息化芯片方面,主要是四核桌面CPU新產品3A6000帶動銷售增長。公司實行“穩員增效”的方針,提高研發投入的效率。公司始終重視軟件生態建設,建成與X86、ARM並列的Linux基礎軟件體系並處於常態化維護階段;目前生態工作的重點在廣泛兼容,即通過二進制翻譯在LA平台運行X86/Linux應用和X86/Windows應用;算力和AI軟件生態是龍架構基礎軟件最後一塊“拼圖”,堅持“兼容主流、擁抱開源、應用牽引、迭代發展”的原則,已取得實質性進展。未來公司計劃推出自主編程框架,發展自主應用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.